Trials / Completed
CompletedNCT00000358
Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7
Safety Evaluation of Lofexidine for Treatment of Opioid Withdrawal
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 0 (planned)
- Sponsor
- National Institute on Drug Abuse (NIDA) · NIH
- Sex
- All
- Age
- 21 Years – 59 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the safety of lofexidine in the treatment of opiate withdrawal. Preliminary data will also be obtained to assess the ability of lofexidine to alleviate opiate withdrawal signs and symptoms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lofexidine |
Timeline
- First posted
- 1999-09-21
- Last updated
- 2017-01-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00000358. Inclusion in this directory is not an endorsement.